PubMed Health⌕ Search

Biomedical subjects

M Debelić

Publications and source records attributed to M Debelić.

30 records · Page 2Linked to original sources

[Inhalation acetylcholine test in chronic non-specific disease of the respiratory tract (author's transl)].

Inhalation tests with 0.5% and 1% acetylcholine chloride wereperformed 374 times in 220 patients with chronic and non-specific respiratory disease and46 control subjects. This simple method, developed by the author, is based on spirographic registration of lungs functions before and after acetylcholine-aerosol inhalation. One hundred and thirty patients with chronic asthma-type bronchitis or intrinsic asthmaand 51 with allergic bronchial asthma had much higher incidence of positive tests [118, i.e. 43%; P less than 0.001] than the group with chronic bronchitis ]5 of 39]or the control group [3 of 46]. There was no significant difference between the lasttwo groups [ 0.5 greater than P less than 0.1]. The inhalation acetylcholine testfacilitates the differential diagnosis of asthmatic syndromes from chronic bronchitis. Ifthe test is positive this suggests an increased bronchomotor reactivity or a non-specificbronchial irritation

Acetylcholine↗

Protection against histamine-induced bronchoconstriction by loratadine.

In a simple blind pilot study we have examined the protective effect of loratadine, a new H1 histamine receptor antagonist, against bronchoconstriction induced by histamine inhalation. Six patients with an episodic or continuing obstructive bronchial disease and proven bronchial hyperreactivity were submitted to two identical histamine challenges, first without premedication and then after three days' treatment with 10 mg loratadine daily. The mean FEV1 fall in the first test after histamine inhalation was 33% and in the second test after pretreatment with loratadine only 3.3% (p less than 0.01). Five out of six patients have shown complete protection against histamine-induced bronchoconstriction, in one patient the protection was partial. We conclude that loratadine effectively inhibits histamine-induced bronchoconstriction and could be useful in the prophylactic treatment of asthma and obstructive bronchitis.

Adult↗